华大九天：大基金等减持计划实施完毕，共减持814.41万股

Core Points - The major shareholders, Da Fund and Shanghai Jianyuan, have completed their share reduction plans for BGI Genomics [1] Summary by Category Shareholder Actions - Da Fund reduced its holdings by 2.7147 million shares, representing 0.5% of the total share capital, between September 15 and October 15 [1] - Shanghai Jianyuan sold 5.4294 million shares, accounting for 1% of the total share capital, from August 13 to October 13 [1] Post-Reduction Holdings - After the reduction, Da Fund holds 45.4781 million shares, which is 8.34% of the total share capital [1] - Shanghai Jianyuan now owns 35.7064 million shares, making up 6.55% of the total share capital [1]